Malignancies

153 drugs in development·69 companies·1 clinical trial

Drug Pipeline by Phase

Approved(8)

Drug	Company
clonoSEQ	Adaptive Biotechnologies Corp (ADPT)
fulphila	Mylan II B.V. (MYL)
Imbruvica	Royalty Pharma plc (RPRX)
keytruda qlex	Merck & Co., Inc. (MRK)
nypozi	GT Biopharma, Inc. (GTBP)
radar	NeoGenomics Inc. (NEO)
ROLVEDON	Assertio Holdings, Inc. (ASRT)
udenyca	Coherus Oncology, Inc. (CHRS)

Phase 3(43)

Drug	Company
avelumab	PFIZER INC (PFE)
azd1390	ASTRAZENECA PLC (AZN)
bat1706	BeOne Medicines Ltd. (BEIGF)
bat1706	BeOne Medicines Ltd. (ONC)
bexobrutideg	Nurix Therapeutics, Inc. (NRIX)
BGB-11417	BeOne Medicines Ltd. (ONC)
bgb-15025	BeOne Medicines Ltd. (ONC)
BGB-15025	BeOne Medicines Ltd. (ONC)
bgb-a445	BeOne Medicines Ltd. (ONC)
BGB-A445	BeOne Medicines Ltd. (ONC)
Cetuximab	BRISTOL MYERS SQUIBB CO (BMY)
cmp 001	PFIZER INC (PFE)
glpg car t-cell therapy	Galapagos NV (GLPG)
GLPG CAR T-cell therapy	Galapagos NV (GLPG)
hmpl-506	HUTCHMED (China) Ltd (HMDCF)
kite-439	Kite Pharma, Inc. (KITE)
kite-585	Kite Pharma, Inc. (KITE)
kite-718	Kite Pharma, Inc. (KITE)
kite-796	Kite Pharma, Inc. (KITE)
lbl-007	BeOne Medicines Ltd. (ONC)
LBL-007	BeOne Medicines Ltd. (ONC)
lenvatinib	BeOne Medicines Ltd. (ONC)
lenvatinib	BeOne Medicines Ltd. (BEIGF)
Leucovorin	Arcus Biosciences, Inc. (RCUS)
Leucovorin Calcium	Arcus Biosciences, Inc. (RCUS)
lorlatanib	PFIZER INC (PFE)
ociperlimab	BeOne Medicines Ltd. (ONC)
ociperlimab	BeOne Medicines Ltd. (ONC)
pamiparib	BeOne Medicines Ltd. (ONC)
pamiparib	BeOne Medicines Ltd. (ONC)
pelabresib	Novartis AG (NVS)
pf04518600	PFIZER INC (PFE)
rosuvastatin	ASTRAZENECA PLC (AZN)
Sirolimus	Filana Therapeutics Inc. (FLNA)
sitravatinib	BeOne Medicines Ltd. (ONC)
sitravatinib	BeOne Medicines Ltd. (BEIGF)
surzebiclimab	BeOne Medicines Ltd. (ONC)
surzebiclimab	BeOne Medicines Ltd. (ONC)
Talazoparib	PFIZER INC (PFE)
Temsirolimus	Filana Therapeutics Inc. (FLNA)
utomilumab	PFIZER INC (PFE)
zanidatamab	BeOne Medicines Ltd. (BEIGF)
zanidatamab	BeOne Medicines Ltd. (ONC)

Phase 2(13)

Drug	Company
AZD9574	ASTRAZENECA PLC (AZN)
BT8009	BICYCLE THERAPEUTICS PLC (BCYC)
cnct19	CASI Pharmaceuticals, Inc (DE) (CASI)
Cytoxan	Filana Therapeutics Inc. (FLNA)
Lurbinectedin 4 MG Injection [Zepzelca]	Jazz Pharmaceuticals plc (JAZZ)
Mycophenolate mofetil	Filana Therapeutics Inc. (FLNA)
ot-101	Oncotelic Therapeutics, Inc. (OTLC)
parsaclisib + ibrutinib	Incyte Corp. (INCY)
parsaclisib + itacitinib	Incyte Corp. (INCY)
REC-3565	RECURSION PHARMACEUTICALS, INC. (RXRX)
skb518	GH Research PLC (GHRS)
TIL	Filana Therapeutics Inc. (FLNA)
trichostatin a	Vanda Pharmaceuticals Inc. (VNDA)

Phase 1(46)

Drug	Company
[11C]AZ1419 3391	PTC THERAPEUTICS, INC. (PTCT)
apg-3288	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
arq 531	ARQULE INC (ARQL)
ATA3431	Atara Biotherapeutics, Inc. (ATRA)
AZD9574	PTC THERAPEUTICS, INC. (PTCT)
bi-1206	CASI Pharmaceuticals, Inc (DE) (CASI)
BI-1808	Merck & Co., Inc. (MRK)
BI-1808	Merus N.V. (MRUS)
calcineurin inhibitor	Incyte Corp. (INCY)
cnty-101	Century Therapeutics, Inc. (IPSC)
cnty-308	Century Therapeutics, Inc. (IPSC)
cnty-341	Century Therapeutics, Inc. (IPSC)
cnty-813	Century Therapeutics, Inc. (IPSC)
Datopotamab Deruxtecan	PTC THERAPEUTICS, INC. (PTCT)
digoxin	ASTRAZENECA PLC (AZN)
DVX201 (Unmodified Natural Killer Cells)	Coeptis Therapeutics Holdings Inc. (COEP)
EOS-984	iTeos Therapeutics, Inc. (ITOS)
EXS73565	RECURSION PHARMACEUTICALS, INC. (RXRX)
ft839	FATE THERAPEUTICS INC (FATE)
furosemide	ASTRAZENECA PLC (AZN)
hec89736	SUNSHINE BIOPHARMA INC. (SBFM)
idh305	NOVARTIS AG (NVSEF)
idh305	Novartis AG (NVS)
il-2	Century Therapeutics, Inc. (IPSC)
IM-1021	Immunome Inc. (IMNM)
inca32459-101	Incyte Corp. (INCY)
incb040093	Incyte Corp. (INCY)
incb040093 + itacitinib	Incyte Corp. (INCY)
JNJ-1493	Xencor Inc (XNCR)
KT-253	Kymera Therapeutics, Inc. (KYMR)
kur-502	Athenex, Inc. (ATNX)
lymphodepleting chemotherapy	Century Therapeutics, Inc. (IPSC)
mvt-1075	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
mvt-2163	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
narazaciclib	TRAWS PHARMA, INC. (ONTX)
Pedmark® STS	Merus N.V. (MRUS)
pelabresib	Novartis AG (NVS)
plogosertib (plogo)	Bio Green Med Solution, Inc. (BGMSP)
rabeprazole	ASTRAZENECA PLC (AZN)
tsc-102-a01	TScan Therapeutics, Inc. (TCRX)
tsc-102-a03	TScan Therapeutics, Inc. (TCRX)
tsc-102-a0301	TScan Therapeutics, Inc. (TCRX)
tti-621	Trillium Therapeutics Inc. (TRIL)
tuspetinib	Aptose Biosciences Inc. (APTOF)
vir-5525	Vir Biotechnology, Inc. (VIR)
zelebrudomide	Nurix Therapeutics, Inc. (NRIX)

Preclinical(19)

Drug	Company
adp-520	Adaptimmune Therapeutics PLC (ADAP)
am0001	ARMO BIOSCIENCES, INC. (ARMO)
am0003	ARMO BIOSCIENCES, INC. (ARMO)
am0012	ARMO BIOSCIENCES, INC. (ARMO)
am0015	ARMO BIOSCIENCES, INC. (ARMO)
car-based product candidate targeting egfrviii	Kite Pharma, Inc. (KITE)
cd38-diagnostic	COEPTIS THERAPEUTICS INC. (NDYN)
CD38-Diagnostic	Coeptis Therapeutics Holdings Inc. (COEP)
cpi-482	CONSTELLATION PHARMACEUTICALS INC (CNST)
duet-02	Scopus BioPharma Inc. (SCPS)
duet-03	Scopus BioPharma Inc. (SCPS)
mink-413	MiNK Therapeutics, Inc. (INKT)
nexi-003	NexImmune, Inc. (NEXI)
onc212	CHIMERIX INC (CMRX)
procel	Kiromic Biopharma, Inc. (KRBP)
sg293	Sana Biotechnology, Inc. (SANA)
tcr-based product candidates targeting ssx2	Kite Pharma, Inc. (KITE)
vadc45	Vor Biopharma Inc. (VOR)
Veto Cell technology	Cell Source, Inc. (CLCS)

Unknown(3)

Drug	Company
a multicenter access	HWH International Inc. (HWH)
clonoSEQ assay (MRD Pharma)	Adaptive Biotechnologies Corp (ADPT)
CYCART-19	Celularity Inc. (CELU)

Early Phase 1(2)

Drug	Company
177lu-im-3050	Immunome Inc. (IMNM)
sgt-53	National Research Corporation Common Stock (Delaware) (NRC)

Phase 1/Phase 2(14)

Drug	Company
[11C]AZ1419 3391	ASTRAZENECA PLC (AZN)
chemotherapy	Incyte Corp. (INCY)
cpi-0209	CONSTELLATION PHARMACEUTICALS INC (CNST)
eb104	Estrella Immunopharma Inc. (ESLA)
incagn01876	Incyte Corp. (INCY)
incagn01949	Incyte Corp. (INCY)
lee011	Novartis AG (NVS)
LEE011	Novartis AG (NVS)
Nemtabrutinib	Merck & Co., Inc. (MRK)
pf-06801591	PFIZER INC (PFE)
sls009	SELLAS Life Sciences Group, Inc. (SLS)
tafasitamab	Incyte Corp. (INCY)
Temozolomide	ASTRAZENECA PLC (AZN)
zugo-cel	CRISPR Therapeutics AG (CRSP)

Phase 2/Phase 3(3)

Drug	Company
AZD5492	ASTRAZENECA PLC (AZN)
enfortumab vedotin-ejfv	Mirati Therapeutics, Inc. (MRTX)
sitravatinib	Mirati Therapeutics, Inc. (MRTX)

Phase 4(2)

Drug	Company
Acalabrutinib	ASTRAZENECA PLC (AZN)
BMS-986523	BRISTOL MYERS SQUIBB CO (BMY)

Compare drugs

clonoSEQ vs fulphila clonoSEQ vs Imbruvica clonoSEQ vs keytruda qlex

Frequently asked questions

How many drugs are in development for Malignancies?

BioSniper tracks 153 drugs in development for Malignancies across 69 companies.

How many clinical trials target Malignancies?

There are 1 clinical trial targeting Malignancies tracked by BioSniper.

Deep-dive into Malignancies

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis